Indegene authorizes TCPA class-action settlement capped at USD 4.72 million
Indegene shareholders approved five resolutions at the 28th AGM, including the appointment of Jill Mary De Simone as an independent director.Summary
Indegene shareholders passed all five resolutions at the company's 28th Annual General Meeting (AGM) held on August 13, 2026. The meeting, conducted via video conferencing, covered routine business such as the adoption of audited financial statements for FY26 and the declaration of a final dividend. The most significant governance change was the appointment of Ms. Jill Mary De Simone as an independent director via a special resolution, which received 91.96% support. The company reported strong financial performance with revenue growing 23.6% to ₹35,105 crore and EBITDA growing 11.1% to ₹6,247 crore. Management highlighted strategic acquisitions, including BioPharm, and emphasized its focus on AI integration through proprietary technology like Cortex. CFO Suhas Prabhu projected that EBITDA margins would normalize by Q4FY27, returning to the historical range of 19% to 20%.
(Source：scanx.trade)